NCT05478824View on ClinicalTrials.gov

IL13 Signaling in Allergic Asthma

RecruitingOBSERVATIONAL

Enrollment

54

Participants

Timeline

Start Date

February 21, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Asthma, AllergicAsthmaObesity

Trial Locations (1)

27208

RECRUITING

Duke Asthma Allergy and Airway Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Duke University

OTHER